Skip to content
BCG — ONE STOP, WE DON’T STOP
Home / Regulatory Information / Device Classification in Korea
REGULATORY INFORMATION

Device Classification in Korea.

Under Annex 1 of the Enforcement Rule of Korea's Medical Devices Act, devices are divided into four risk classes. The review authority and technical documentation review period vary by classification.

Class 1

  • Definition: Devices with minimal potential risk
  • Examples: Manual wheelchairs, examination lights, vision charts and examination gloves
  • Technical documentation review body: National Institute of Medical Device Safety Information (NIDS)
  • Technical documentation review period: 5 business days
  • Technical documentation review fee: KRW 85,000
  

Class 2

  • Definition: Devices with low potential risk
  • Examples: Syringes, patient monitors, powered wheelchairs, low-frequency stimulators and surgical gloves
  • Technical documentation review bodies: MFDS-designated bodies (KTL, KTR, KCL, KTC, etc.)
  • Technical documentation review period: 25 business days for initial review; 15 business days for changes
  • Technical documentation review fee: KRW 2,400,000 for initial review; KRW 1,800,000 for changes
  

Class 3

  • Definition: Devices with moderate potential risk
  • Examples: Joint prostheses, CT scanners, dental implants, ventilators, peritoneal dialysis equipment and fluoroscopy systems
  • Technical documentation review authority: Ministry of Food and Drug Safety (MFDS), Korea
  • Technical documentation review period: 55 business days without clinical trial data; 70 business days with clinical trial data
  • Technical documentation review fee: KRW 561,000 without clinical trial data; KRW 1,338,000 with clinical trial data 
  

Class 4

  • Definition: Devices with high potential risk
  • Examples: Breast implants, pacemakers, cardiopulmonary bypass systems, tissue repair biomaterials and vascular grafts
  • Technical documentation review authority: Ministry of Food and Drug Safety (MFDS), Korea
  • Technical documentation review period: 55 business days without clinical trial data; 70 business days with clinical trial data
  • Technical documentation review fee: KRW 561,000 without clinical trial data; KRW 1,338,000 with clinical trial data   
PATH TO SUCCESS

Need expert support?
Get in touch with our team.

Contact Us